SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-324890
Filing Date
2017-10-30
Accepted
2017-10-30 16:06:02
Documents
2
Group Members
CHRISTOPHER ALAFI, PH.DMOSHE ALAFI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A AMENDMENT NO. 2 d470140dsc13da.htm SC 13D/A 131105
2 EX-99.1 d470140dex991.htm EX-99.1 5734
  Complete submission text file 0001193125-17-324890.txt   138297
Mailing Address PO BOX 7338 BERKELEY CA 94707
Business Address
ALAFI CAPITAL CO LLC (Filed by) CIK: 0001216017 (see all company filings)

IRS No.: 943359302 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Subject) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87380 | Film No.: 171162362
SIC: 2834 Pharmaceutical Preparations